Viewing Study NCT05468294


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-31 @ 11:04 PM
Study NCT ID: NCT05468294
Status: UNKNOWN
Last Update Posted: 2022-07-21
First Post: 2022-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE1 View
None PHASE2 View
Observational Models:
Time Perspective List:
Who Masked List: